CTSZ
Basic information
Region (hg38): 20:58985686-59008238
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CTSZ gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 15 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 11 | 12 | ||||
Total | 0 | 0 | 27 | 4 | 3 |
Variants in CTSZ
This is a list of pathogenic ClinVar variants found in the CTSZ region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-58986131-G-T | not specified | Uncertain significance (Feb 03, 2022) | ||
20-58987804-C-G | not specified | Uncertain significance (Apr 07, 2022) | ||
20-58988969-A-G | not specified | Uncertain significance (Apr 23, 2024) | ||
20-58989901-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
20-58989904-T-C | not specified | Uncertain significance (Apr 06, 2024) | ||
20-58989912-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
20-58990918-A-G | not specified | Uncertain significance (Oct 14, 2023) | ||
20-58991036-C-G | not specified | Uncertain significance (Jun 03, 2022) | ||
20-58991046-A-G | not specified | Uncertain significance (May 30, 2023) | ||
20-58991053-T-C | not specified | Uncertain significance (Feb 17, 2022) | ||
20-58991378-C-A | not specified | Uncertain significance (Jul 30, 2023) | ||
20-58991417-G-T | not specified | Uncertain significance (Aug 02, 2021) | ||
20-58991423-A-G | not specified | Uncertain significance (Oct 13, 2023) | ||
20-58993122-C-T | Benign (Jun 27, 2018) | |||
20-58993452-A-G | not specified | Uncertain significance (Nov 08, 2022) | ||
20-58993721-A-G | not specified | Uncertain significance (Feb 22, 2023) | ||
20-58993760-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
20-58994221-C-T | not specified | Uncertain significance (May 30, 2023) | ||
20-58995735-C-T | not specified | Uncertain significance (Dec 04, 2023) | ||
20-58995756-C-T | not specified | Uncertain significance (Nov 22, 2021) | ||
20-58996649-C-T | not specified | Uncertain significance (Oct 27, 2021) | ||
20-58996734-T-C | not specified | Uncertain significance (Feb 12, 2024) | ||
20-58996738-C-G | not specified | Likely benign (Aug 19, 2023) | ||
20-58996763-G-C | Benign (May 09, 2018) | |||
20-58997654-A-G | Benign/Likely benign (May 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CTSZ | protein_coding | protein_coding | ENST00000217131 | 6 | 12063 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.26e-16 | 0.000589 | 125678 | 0 | 70 | 125748 | 0.000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.600 | 150 | 172 | 0.871 | 0.0000102 | 1953 |
Missense in Polyphen | 50 | 62.318 | 0.80234 | 660 | ||
Synonymous | -0.178 | 75 | 73.1 | 1.03 | 0.00000503 | 585 |
Loss of Function | -1.70 | 20 | 13.3 | 1.50 | 5.68e-7 | 154 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000913 | 0.000912 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.000113 | 0.000109 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000277 | 0.000273 |
Middle Eastern | 0.000113 | 0.000109 |
South Asian | 0.000464 | 0.000457 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Exhibits carboxy-monopeptidase as well as carboxy- dipeptidase activity.;
- Pathway
- Lysosome - Homo sapiens (human);Apoptosis - Homo sapiens (human);Lysosome Vesicle Biogenesis;Clathrin derived vesicle budding;Neutrophil degranulation;trans-Golgi Network Vesicle Budding;Peptide hormone metabolism;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Metabolism of Angiotensinogen to Angiotensins;Innate Immune System;Immune System;Cargo concentration in the ER;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport
(Consensus)
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- 0.573
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.25
Haploinsufficiency Scores
- pHI
- 0.0927
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.434
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.713
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ctsz
- Phenotype
- normal phenotype; neoplasm; cellular phenotype;
Gene ontology
- Biological process
- angiotensin maturation;proteolysis;endoplasmic reticulum to Golgi vesicle-mediated transport;negative regulation of plasminogen activation;negative regulation of neuron projection development;negative regulation of protein binding;neutrophil degranulation;positive regulation of neuron apoptotic process;COPII vesicle coating;proteolysis involved in cellular protein catabolic process;epithelial tube branching involved in lung morphogenesis;regulation of neuron death;positive regulation of neural precursor cell proliferation
- Cellular component
- Golgi membrane;extracellular region;extracellular space;lysosome;endoplasmic reticulum;endoplasmic reticulum lumen;plasma membrane;cell surface;COPII-coated ER to Golgi transport vesicle;growth cone;cytoplasmic vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane;specific granule lumen;intracellular membrane-bounded organelle;collagen-containing extracellular matrix;extracellular exosome;cell cortex region;ficolin-1-rich granule lumen
- Molecular function
- carboxypeptidase activity;cysteine-type endopeptidase activity;protein binding;cysteine-type peptidase activity